Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-01-2016 | Letter to the Editor

Patient’s weight: a neglected cause of variability in SUV measurements? A survey from an EARL accredited PET centre in 513 patients

Authors: Charline Lasnon, Benjamin Houdu, Emmanuel Kammerer, Thibault Salomon, Jeremy Devreese, Adrien Lebasnier, Nicolas Aide

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 1/2016

Excerpt

Dear Sir, …

Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 2015;42:328–54. doi:10.1007/s00259-014-2961-x.PubMedCentralCrossRefPubMed

Lasnon C, Desmonts C, Quak E, Gervais R, Do P, Dubos-Arvis C, et al. Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients. Eur J Nucl Med Mol Imaging 2013;40:985–96. doi:10.1007/s00259-013-2391-1.PubMedCentralCrossRefPubMed

Makris NE, Huisman MC, Kinahan PE, Lammertsma AA, Boellaard R. Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures. Eur J Nucl Med Mol Imaging 2013;40:1507–15. doi:10.1007/s00259-013-2465-0.CrossRefPubMed

Quak E, Le Roux PY, Hofman MS, Robin P, Bourhis D, Callahan J, et al. Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients. Eur J Nucl Med Mol Imaging 2015. doi:10.1007/s00259-015-3128-0.PubMedCentralPubMed

European Association of Nuclear Medicine. EARL FDG-PET/CT accreditation. 2015. http://earl.eanm.org/cms/website.php?id=/en/projects/fdg_pet_ct_accreditation.htm.

Graham MM, Wahl RL, Hoffman JM, Yap JT, Sunderland JJ, Boellaard R, et al. Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials. J Nucl Med 2015;56:955–61. doi:10.2967/jnumed.115.158402.CrossRefPubMed

da Silva AM, Fischer A. WE-AB-204-05: harmonizing PET/CT quantification in multicenter studies: a case study. Med Phys 2015;42:3660. doi:10.1118/1.4925881.CrossRef

Boellaard R. Standards for PET image acquisition and quantitative data analysis. J Nucl Med 2009;50 Suppl 1:11S–20S. doi:10.2967/jnumed.108.057182.CrossRefPubMed

Boellaard R. Methodological aspects of multicenter studies with quantitative PET. Methods Mol Biol 2011;727:335–49. doi:10.1007/978-1-61779-062-1_18.CrossRefPubMed

10.

Boellaard R. Mutatis mutandis: harmonize the standard! J Nucl Med 2012;53:1–3. doi:10.2967/jnumed.111.094763.CrossRefPubMed

11.

Beyer T, Czernin J, Freudenberg LS. Variations in clinical PET/CT operations: results of an international survey of active PET/CT users. J Nucl Med 2011;52:303–10. doi:10.2967/jnumed.110.079624.CrossRefPubMed

12.

Graham MM, Badawi RD, Wahl RL. Variations in PET/CT methodology for oncologic imaging at U.S. academic medical centers: an imaging response assessment team survey. J Nucl Med 2011;52:311–7. doi:10.2967/jnumed.109.074104.PubMedCentralCrossRefPubMed

13.

Binns DS, Pirzkall A, Yu W, Callahan J, Mileshkin L, Conti P, et al. Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging 2011;38:642–50. doi:10.1007/s00259-010-1665-0.CrossRefPubMed

14.

Hristova I, Boellaard R, Vogel W, Mottaghy F, Marreaud S, Collette S, et al. Retrospective quality control review of FDG scans in the imaging sub-study of PALETTE EORTC 62072/VEG110727: a randomized, double-blind, placebo-controlled phase III trial. Eur J Nucl Med Mol Imaging 2015;42:848–57. doi:10.1007/s00259-015-3002-0.PubMedCentralCrossRefPubMed

15.

Rowland ML. Self-reported weight and height. Am J Clin Nutr 1990;52:1125–33.PubMed

Title: Patient’s weight: a neglected cause of variability in SUV measurements? A survey from an EARL accredited PET centre in 513 patients
Authors: Charline Lasnon
Benjamin Houdu
Emmanuel Kammerer
Thibault Salomon
Jeremy Devreese
Adrien Lebasnier
Nicolas Aide
Publication date: 01-01-2016
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 1/2016
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-015-3214-3

At a glance: The STEP trials

Springer Medicine

Patient’s weight: a neglected cause of variability in SUV measurements? A survey from an EARL accredited PET centre in 513 patients

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2016

Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [11C]ABP688 PET

Textural analysis of pre-therapeutic [18F]-FET-PET and its correlation with tumor grade and patient survival in high-grade gliomas

Paget bone disease demonstrated on 68Ga-PSMA ligand PET/CT

Erratum to: Difficulties in deciding whether to ablate patients with putatively “low–intermediate-risk” differentiated thyroid carcinoma: do guidelines mainly apply in the centres that produce them? Results of a retrospective, two-centre quality assurance study

Dosimetry for 177Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer

Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer